Arab Journal of Gastroenterology
Volume 10, Issue 4, Supplement , Pages S21-S22 , April 2010

Antifibrotic agents emerging from traditional herbal medicine

References 

  1. Friedman SL. The cellular basis of hepatic fibrosis. N Engl J Med. 1993;328:1828–1835
  2. Okuyama H, Shimahara Y, Kawada N. The hepatic stellate cells in the post-genomic ear. Histol Histopathol. 2002;17:487–495
  3. Kojima S, Hayashi S, Shimokado K, et al. Transcriptional activation of urokinase by the Kruppel-like factor Zf9/COPEB activates latent TGF-beta 1 in vascular endothelial cells. Blood. 2000;95:1309–1316
  4. Inagaki Y, Nemoto T, Nakao A, et al. Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific alpha 2(I) collagen gene transcription. J Biol Chem. 2001;276:16573–16579
  5. Kinoshita K, Iimuro Y, Otogawa K, et al. Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut. 2007;56:706–714
  6. Kawada N, Tran-Thi TA, Klein H, et al. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem. 1993;213:815–823
  7. Rockey DC, Weisiger RA. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology. 1996;24:233–240
  8. Bonis PA, Friedman SL, Kaplan MM. Is liver fibrosis reversible?. N Engl J Med. 2001;344:452–454
  9. Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol. 2004;40:860–867
  10. Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O, et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Int Med. 2000;132:517–524
  11. Okuyama H, Shimahara Y, Kawada N, et al. Regulation of cell growth by redox-mediated extracellular proteolysis of platelet-derived growth factor receptor beta. J Biol Chem. 2001;276:28274–28280
  12. Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med. 1999;5:226–230
  13. Ikeda K, Arase Y, Kobayashi M, Saitoh S, Someya T, Hosaka T, et al. A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients. Dig Dis Sci. 2006;51:603–609
  14. Uyama N, Shimahara Y, Okuyama H, Kawada N, Kamo S, Ikeda K, et al. Carbenoxolone inhibits DNA synthesis and collagen gene expression in rat hepatic stellate cells in culture. J Hepatol. 2003;39:749–755
  15. Oka H, Yamamoto S, Kuroki T, Harihara S, Marumo T, Kim SR, et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer. 1995;76:743–749
  16. Shimizu I, Ma YR, Mizobuchi Y, Liu F, Miura T, Nakai Y, et al. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology. 1999;29:149–160
  17. Sakaida I, Matsumura Y, Akiyama S, Hayashi K, Ishige A, Okita K. Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet. J Hepatol. 1998;28:298–306
  18. Shoda J, Miura T, Utsunomiya H, Oda K, Yamamoto M, Kano M, et al. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver. Hepatology. 2004;39:167–178
  19. Imanishi Y, Maeda N, Otogawa K, Seki S, Matsui H, Kawada N, et al. Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats. J Hepatol. 2004;41:242–250

PII: S1687-1979(09)00314-1

doi: 10.1016/j.ajg.2009.12.007

Arab Journal of Gastroenterology
Volume 10, Issue 4, Supplement , Pages S21-S22 , April 2010

Article Tools